News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Kayyem Jon Faiz
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 6,172 shares
@ $1.62, valued at
$10k
|
|
| 05/25/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 28,873 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Exercised 145,833 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 9,500 shares
@ $25.2631, valued at
$240k
|
|
| 01/05/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 4,878 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Granted 62,500 restricted stock units
@ $0 |
|
| 11/22/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 2,733 shares
@ $29.3279, valued at
$80.2k
Sold 6,767 shares
@ $30.1196, valued at
$203.8k
|
|
| 11/21/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on BIODESIX INC|
Txns:
| Bought 173,913 shares
@ $1.15, valued at
$200k
|
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 11,900 shares
@ $0 |
|
| 08/08/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 3,400 shares
@ $0 |
|
| 08/02/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 118,500 shares
@ $0
Gifted 25,000 shares
@ $0 |
|
| 05/26/2022 |
4
| Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Granted 15,000 options to buy
@ $12.57, valued at
$188.6k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/18/2020 |
3
| Kayyem Jon Faiz (10% Owner) has filed a Form 3 on Inhibrx, Inc. |
| 02/06/2018 |
4
| Kayyem Jon Faiz (SVP, Research & Development) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Sold 148 shares
@ $5.13, valued at
$759.2 |
|
| 12/06/2017 |
4
| Kayyem Jon Faiz (SVP, Research & Development) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Sold 135 shares
@ $4.7, valued at
$634.5 |
|
| 11/21/2017 |
4
| Kayyem Jon Faiz (SVP, Research & Development) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Sold 1,269 shares
@ $4.74, valued at
$6k
|
|
| 11/03/2017 |
4
| Kayyem Jon Faiz (SVP, Research & Development) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Sold 135 shares
@ $7.24, valued at
$977.4 |
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|